Research involving children or other incompetent subjects who are deemed unable to provide informed consent is complex, particularly in the case of research that does not directly benefit the research subjects themselves. The Helsinki Declaration, the World Medical Association's landmark document for research ethics, therefore states that incompetent research subjects must not be included in such research unless it entails only minimal risk and minimal burden. In this paper, we argue that now that research in these groups is expected to expand, this undifferentiated minimal risk and burden requirement does not suffice any more. In the upcoming revision of the Declaration, the paragraph at stake should be refined in such a way that it is not unnecessarily restrictive or more permissive than can be ethically justified. Our first recommendation is to stimulate research ethics committees to identify more accurately those risks and burdens that the research subjects must undergo solely for research purposes by distinguishing between two types of study procedures instead of between two types of studies. Our second recommendation is to allow for exceptions to the minimal risk and burden requirement in cases of exceptionally valuable studies that involve subjects who can give their assent to participate in the study and that involve at most a minor increase over minimal risk and/or burden.
- Research Ethics
- Ethics Committees/Consultation
- Clinical trials
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Acceptable risks and burdens for children in research without direct benefit: a systematic analysis of the decisions made by the Dutch Central Committee
- Ambiguous articles in new EU Regulation may lead to exploitation of vulnerable research subjects
- Drug development for children: how adequate is the current European ethical guidance?
- To stop or not to stop: dissent and undue burden as reasons to stop participation in paediatric research
- Are positive experiences of children in non-therapeutic research justifiable research benefits?
- Is best interests a relevant decision making standard for enrolling non-capacitated subjects into clinical research?
- Process of risk assessment by research ethics committees: foundations, shortcomings and open questions
- The structure of ethics review: expert ethics committees and the challenge of voluntary research euthanasia
- Ethical concerns regarding guidelines for the conduct of clinical research on children
- Non-therapeutic research with minors: how do chairpersons of German research ethics committees decide?